Why Did the Cannabis Sector Jump 50%?

Get in on the ground level with these cannabis-investing opportunities! [CWN-Spotlight](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fql5nXHsW50kH_H6lZ3n_W1QnpH23xCL7VVYs2PK4DFsTHW7_qvpM6k9dPGN2dckj49x_c8W8mv90y8pFkZdW6Bzkf69kTBQBW3lBXsP8_Bn0dN1FLdctN4GkPW8RbYRH8y84JPW7yC1_r6SJTjxW8qb3ZP5MrqBTW8QhRtY1XrPXBW1MVPBL72GtklW8TYfPc1w363BW1-NH0p6yHz7CW4kzBkV7gwghhW5d_dMb3ZtfVNW97SB9J1Lvm8sVMbKgM4HQQkrW39sJ6x8pB0kJW7shtwr8nBJnRW5yypcM96xDkWW1xYQT42xpc86N1FNJ87Lb6kqW2G1hLp20m2LMW7zFBZl4KNVz7W19qk_y6Ftj7xW1lBXxb6DV1GSMLHPZFy61LWW5ZgRbM2G00S4W7cfmdq8W9_DzF4MXNPB5Npkf5VMZzW04) FROM THE DESK OF: Ed Coburn, President Now with news from the Federal Government that it plans to change the legal designation of cannabis… the whole sector is on the move. We’ve seen huge gains in just the last week. Don’t miss out. Please read on. Ed [Federal Recommendation to Reclassify Marijuana Opens Door to Full Legalization…and Sparks the Next Big Cannabis Rally](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fql5nXHsW50kH_H6lZ3mYW6vzLk_5TrcZfW8Z-jFk16rnZDW8jk1xb7qCHTMMLwX6ZmftW1W7Cj9W52b0-NwW7K8y46438hMMW29368F6Whkl8W30_Z2s8Lmp3WW31mJDl95wGm4W8P0m6g27MmBjW8QM6_y8jb-YzW7b9Whh91h6BSN1vd5WRHcxZ6W4RptvK5cVtMLW5NNn5D74Jhj_W4zR9Rn4_YYyyW7QW5_s2yhbXSW9lbJN14HzcJBW6rt_Zc8N7nrMN3-_HTbLjckNW6kFLQL7f3njzVDyLvL3QgQq3W13GZ-372hK-SW7ngJqm781wcQW3jy1gB8GyVQ-W7wLJqN8GLwFzW7KJx5B7XhcKlW3p2RFF7YtpyyW2KD2ft1GCg2VVv6yYK1xYYxZW3QsF7s5BrznnW8WF-j34xhLKDf3F158404) “Call To Reschedule Marijuana Is A Big Deal” -Forbes, August 31, 2023 Dear Fellow Investor, In case you missed it, the Department of Health & Human Services and the Food & Drug Administration both recommended to reclassify marijuana from its current Schedule 3 classification (same classification as heroin and fentanyl) to Schedule 1 (the same classification as what’s legally sold in drug stores). This reclassification opens the door for Congress to pass the SAFE Banking Act which will give the cannabis industry access to financial services comparable to other industries. And, importantly, allow the use of credit and debit cards for retail purchases. In addition to being big steps towards Federal legalization, these developments will grow the market for legal cannabis. And, just as important, attract more investors and ultimately the institutional investors that will drive even further gains in cannabis stocks. In fact, there’s lots of good news … - The U.S. House of Representatives passed a bill decriminalizing cannabis for the first time since 1937. - More states than ever have legalized recreational cannabis. - The United Nations could soon reverse the 1961 U.N. Single Convention on Narcotics—which would open most of the rest of the world to legal cannabis. As a result, Cannabis stocks are on the move… The Roundhill Cannabis ETF (WEED) is up 50% in just the past week… [WEED ETF] Many individual stocks are up even more in the same time period. Even better, the investment portfolio created by Cabot Cannabis Investor Chief Analyst Michael Brush is beating the industry benchmark by 13-fold as of September 5. Why Is Reclassifying Cannabis Such a Big Deal? The Federal Government classifies drugs under different “Schedules” that refer to how dangerous a drug can be, or whether it has medical or recreational uses. Today, cannabis is still a Schedule I drug, along with drugs like heroin, bath salts and GHB (the date rape drug). Almost no one thinks it makes sense to categorize it alongside a drug like heroin, which according to the National Institute of Health kills nearly 100,000 Americans every year. Moving cannabis to Schedule III changes everything. For one, it means cannabis has medical and therapeutic uses, it’s not very dangerous, and it’s not addictive. It also paves the way for total legalization at the Federal level, as Schedule III drugs are sold in pharmacies across the country. They’re legal to possess, sell, and manufacture. And it’s not just in the U.S. Despite many US states slowly decriminalizing … there’s still a shockingly small number of countries worldwide that have made cannabis completely legal. In fact, it is currently only 3. Only North Korea, Uruguay, and Canada have completely legalized cannabis; meaning, most of the world’s cannabis markets are still underground and ripe for massive growth once legalization occurs … 99% of the globe remains untapped. However, some of the most influential signatories to the 1961 treaty (including the US, the UK, and now Germany) are already changing course on cannabis…and they could be just the tip of the iceberg. But almost no one knows about this opportunity… Most investors think the growth is over and all the gains are already baked in. The real story: There hasn’t been a better time to buy quality cannabis companies for bargain prices in at least a decade. And the best part…American cannabis stocks have a head start. Please read on to discover why American stocks are poised for growth—and how you can take advantage of impending legalization. This Is the Story You Haven’t Heard About American Cannabis (Including One More Massive Catalyst That Could Kick Off Soon) … You see, all of the big names in Cannabis have something in common—a factor that’s holding their stock prices back even as global legalization gets closer to reality. That’s for a simple reason: There are two very different kinds of companies in the cannabis sector. No, I’m not talking about CBD vs. THC—or medical marijuana vs. recreational … I’m talking about two very distinct kinds of publicly-traded companies. One type is the kind you’ve probably heard about: The Canopy Growth types. They’re large, and they trade on major exchanges—but, even more important, they’re headquartered in Canada. In fact, all of the biggest marijuana companies are Canadian. Canopy … Aphria, Aurora … almost every company on the Nasdaq and NYSE has a Canadian headquarters. However, because of Federal marijuana laws, Canadian companies can’t sell product in the US. But they can list their stocks on American exchanges like the NYSE and Nasdaq. That’s why many of the earliest cannabis companies decided to go public in the US, even while they have operations in Canada, where cannabis is already 100% legal. While they’re grabbing the money from Wall Street, they are the first companies to lose when global legalization occurs. The second type of cannabis company is entirely different … These companies are American. BUT, because cannabis is still Federally illegal, these companies cannot get listed on a major exchange. They can’t get onto a major exchange because of various banking regulations and listing requirements for the NYSE and Nasdaq. In fact, these companies can’t even access traditional banks. But, that brings me to another huge catalyst that no one is talking about: It’s a new banking regulation change called The Secure and Fair Enforcement Act, known as the SAFE Banking Act. Overnight, this Act would give American cannabis companies the ability to access traditional banking without the fear of breaking Federal Law. Until that happens, these companies are still only available on ... Over-the-Counter exchanges. It’s basically the Wild West of American stocks. They also have 5-letter ticker symbols—which is why I call them “5-ticker” stocks. There is little oversight, and it’s way easier to get listed on the OTC exchange. In fact, it takes just a single piece of registration paperwork to get listed! They also tend to be smaller compared to the first type. Most of them have a market cap between $1 billion and $10 billion—which would make them small caps on any major exchange. And they’re very regional. For instance, there’s one company that only has operations in Pennsylvania, California, and New Jersey. It’s not listed on the NYSE or the Nasdaq … It’s a “5-ticker” company, still under the radar of mainstream cannabis investors. Right now, this company (and a handful of market-dominating American companies) are still legally prevented from being added to the New York Stock Exchange or the Nasdaq … That All Changes the Day Congress Passes the Safe Banking Act … Then: A cascade of companies can rush to join major exchanges … And they’ll be able to access billions in new investment capital from institutions, mutual funds, pension funds, and American banks … Think about the wave of investment coming into American cannabis stocks when every index fund has to buy shares … Vanguard has over $6 trillion in assets under management. Fidelity has over $3 trillion. Schwab has $4 trillion. If even 1% of this $13 trillion from the top mutual funds ends up in American cannabis stocks in the next 5 years, that’s over $130 billion flooding into the sector … And, I’m not even adding in what individual investors, pension funds, or hedge funds will throw onto the pile … That tidal wave of cash hitting this select group of “5-ticker” cannabis stocks will be like nothing we’ve ever seen before in cannabis investing. America is the world’s biggest cannabis market, and these “5-ticker” stocks are all poised to surge when Congress votes to legalize marijuana. And that says NOTHING about what happens when the U.N. reforms it’s 60 plus-year-old convention … Even without U.N. reforms … the American cannabis industry is poised to grow 12% a year for the next several years. Don’t take my word for it: Leading Cannabis Analyst, Vivian Azer, projected U.S. cannabis sales to grow 12% to hit $45.6 billion in 2027. Again: Her projection is not taking into account any kind of expanded legalization in the US or abroad … And she’s also not alone: Canadian Imperial Bank of Commerce Analyst, John Zamparo, projected 13% minimum growth over the next year. No one in the mainstream gets this … You might have heard of Over-the-Counter Stocks before … If you have, you might have heard them called “penny stocks.” And most of the time, penny stocks are a pure gamble. But these “5-ticker” marijuana stocks I’m going to tell you about today are not your average penny stock. For one … they’re all established, operating businesses with real profits, employees, and operations. All of these companies are worth over $1 billion. That makes them giants in the world of penny stocks: And they stand to soar very soon … That’s because they’re all waiting, like racehorses at the gate, for Federal decriminalization. As soon as that happens, many of these completely under-the-radar “5-ticker” over-the-counter stocks will start the process to get uplisted to a major exchange. That might not sound like a big deal … but, you have to understand: Getting uplisted to a major exchange is a HUGE payday for early investors. Take Canopy Growth—one of the largest cannabis companies on the market. It traded on Canadian penny stock markets for 4 years … then, it announced it would start listing on the NYSE … and look what happened next: [Canopy Trades Flat] Now, I’m not saying you should wait until “5-ticker” cannabis stocks announce that they’ll list on a major exchange. Notice the stock started to move BEFORE the up-listing announcement … It’s true. If you had bought 6 months before the announcement in December of 2017, when the stock was $15, you could have made 230% instead of 82%. We’re in that period right now for many of these 5-ticker companies. But again: If you WAIT until these companies announce, well, your gains will suffer. Take a look at what happened with another giant Canadian cannabis company: Aurora, after it announced it would list on the NYSE: [Aurora] Or take Aphria: Another company that listed as a penny stock in Canada for years—and then on October 18, 2018, it announced it would list on the NYSE … If you bought it on that date, you didn’t do too well. The stock had already surged. That’s because the writing was on the wall for Aphria. The best time to buy it was in the year leading up to the announcement. Take a look: [Aphria] But how do you know when one of these stocks is ready to move? You can start by subscribing to Cabot Cannabis Investor. It’s one of the first investment research advisories focused entirely on marijuana, and it’s run by a talented analyst named Michael Brush. Right Now We’re About to Enter Another Era of Massive Gains in the Cannabis Sector—Focused Almost Entirely On American Companies … That’s why Michael has made a short list of American cannabis companies—all trading on the OTC exchange—poised to get uplisted as soon as Congress decriminalizes marijuana sometime in the next year … It’s all in a brand-new report Michael just published called “3 American Cannabis Companies to Own BEFORE Legalization.” Owning these companies today is like buying Canopy Growth before it got uplisted to the NYSE in 2018 and jumped 230% … Or, like buying Aurora before it jumped 230% … Or, like being an Aphria shareholder before the company got uplisted and jumped 370% … But, it’s actually an even better opportunity … Think about the size of the Canadian cannabis market compared to the U.S. market… Canadians bought over CA$4.5 billion (or $3.35 billion U.S. dollars) worth of recreational marijuana products in 2022. Not too shabby … But, the American market is projected to be 8 times bigger … That means American cannabis companies will sell more than $25 billion a year by 2025. Which means American companies could be 8 times more profitable to own BEFORE they get uplisted than their Canadian counterparts have been. This is truly a rare chance to get in on a major move in 100% American companies all under the radar … waiting for that day when cannabis is legal and they can jump to a major exchange. And, I believe we’ll see gains that will dwarf what we saw in Canadian companies, before they got listed on a major exchange. Also … that doesn’t even consider what happens when the U.N. reforms its 62-year cannabis convention … Global legalization could double or triple the size of the market over the size of America’s market … We could be just months away … Right now, many investors are sitting on their hands … waiting for full U.S. legalization to pass before they pile into American pot stocks—or even worse: Many of them will wait until these companies uplist. By then? Well, I think it will be too late to see significant profits. The time to act is now. Let me tell you a little about these companies, so you can see for yourself why now is the perfect time to buy into America’s next marijuana bull market … American Cannabis Companies to Own Today All three of the companies in this report: 3 American Cannabis Companies to Own BEFORE Legalization, are what I call “market dominators.” They have very specific regions where they are the biggest marijuana game in town. They’re all poised to become massive household names—like Pepsi, Coca-Cola, Budweiser, and Coors. I believe if you buy these companies today—before they announce that they’re getting uplisted—you will make a killing when Congress legalizes cannabis. And when decriminalization passes? They’ll be in the driver’s seat to expand to every state in the union. More important: If you buy them today, you’ll be ready for the next leg up in the cannabis sector. And even better, I’d like to give you a copy of this report, today. How to Get a Copy of 3 American Cannabis Companies to Own Before Legalization As I said, Cabot Cannabis Investor is one of the first cannabis investing advisories that focuses exclusively on cannabis opportunities. Michael’s goal is to get you into marijuana’s best opportunities—before Wall Street takes notice and the companies grow into the Budweisers and Coca-Colas of the industry … As a subscriber, you’ll discover every month North America’s most profitable cannabis companies. Michael walks you through their grow houses, manufacturing facilities, retail locations, pharmaceutical products, and profit potential. Just as important, he will help you navigate the cyclical nature of this sector. Today, I’d like to invite you to become a subscriber of Michael’s service. And when you do, you get a copy of the foundational Cabot Cannabis Investor report: 3 American Cannabis Companies to Own BEFORE Legalization. This report will not only bring you the full story of all of these stocks, but also a complete and thorough analysis of how they’re performing, what the growth trajectory is—and, when you’ll know it’s time to take profits. All 3 of the companies in this report are exactly the kind of companies that are expected to soar when Congress decriminalizes cannabis. When that happens ... they can uplist to the Nasdaq, or the NYSE. And I’ll send you this report right now—all I ask is that you give Cabot Cannabis Investor a try … [Click Here to Claim Access to This Report Now!](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fql5nXHsW50kH_H6lZ3lyVRxfMk9dvZC8W2LwkFP4Nn-yXW2Kxh_k7RdxzmW2ktmjg5y84xVW234hyz4XQwhTW7qj-Km6H_xzNW3FsBc_52DBzPW92QsHz50hhx8W4Rtz182FX3NbN18jX28Fqh3PW4Nr2Kt7-zqxBW3ZgtBN2J8WxSW1CgdVf3xBRgSW5m431D6c7R64M_vKf3pBwjCW5b4sPx64kbWjW7LGHCW1YfkjQVJWrmx91Qcw0W13b8YV2YzZylW7W1d421NX5xsVT0dJf6S8BMhN6kGFpQ2bLRyW2d5mXz66JP9mMj6HnRngr_WW53JSjh6B9sgxMgr4by81JgxW6b8FTT2_Qw9xW2JcZnL56FFl_W2Sr2b166-HVSW8D0LN08t1Z7vW68wphY6CV44dW8NQw5W1rqNqBf6MkPyF04) Here’s What You’ll Like Best About Cabot Cannabis Investor: - It’s published by Cabot—a leading investment and research advisory for more than 50 years. In a world where hundreds of investments advisories come and go each year, Cabot has stood the test of time for more than five decades. As a result, investors around the world count on our institutional-level research and independent, unbiased—and, most important of all, profitable—investing advice to help them build their wealth safely and systematically. - You gain complete access to Cabot’s time-tested, profitable, stock-picking approach applied directly to the marijuana industry. It’s how Michael has been able to put his readers into a select group of cannabis investments that have beaten the New Cannabis Ventures index benchmark by 13-fold this year (as of September 5). - You get our monthly private briefings and monthly updates. They’re full of detailed technical and fundamental analysis. The only way to describe our private briefings is to compare them to the economic forecasts issued by major research firms like Gartner and PricewaterhouseCoopers. Each issue will bring you institutional-level profit profiles of the companies leading this growing industry and instructions on how to assemble them to add them to your holdings, along with a panoramic overview of recent and upcoming events that will affect your money. If you have already profited from our Cabot Growth Investor, Cabot Small-Cap Confidential, Cabot Top Ten Trader, Cabot Options Trader, or Cabot Explorer advisories, then you already know we bring you only the highest level of profitable research and recommendations. If you are new to Cabot, today’s message offers you a sneak preview of the kind of complete economic analysis and investment recommendations we’ll bring you when you join us. - You also get regular updates and portfolio adjustments. As Michael tells his readers, in order to beat the market, you must regularly adjust your holdings to make sure you own the stocks that are leading the sector through increasing sales and earnings. - You get complete access to our private website. As a subscriber, you’ll receive 24/7 access to our private website, which features the most recent updates and alerts, your FREE special report, and our archive of our past issues and reports—all fully accessible by you with a click of a mouse. As soon as I receive your response, I’ll send you login information so you can download your FREE report, read your first issue, and add our newest picks to your holdings before they breakout. The moment you agree to give us a try, you’ll get instant access to the special report, 3 American Cannabis Companies to Own BEFORE Legalization which will give you the full details on the three American companies poised to benefit from legalization. They’re just the beginning of the financial windfall that is headed your way. That’s why we launched Cabot Cannabis Investor and why I’ve made it possible for you to get in on the ground floor of these opportunities without risk. The big money is being made now. Cabot Cannabis Investor makes it so easy, convenient, inexpensive, and risk-free to profit from this boom that there is nothing to stand in your way. Act Now to Get Your Life-Changing Subscription to Cabot Cannabis Investor If you have read this far, you can tell that Cabot Cannabis Investor is a different kind of service—one that not only focuses squarely on this $50 billion-a-year industry, but also brings you institutional-level research you won’t find anywhere else. I don’t want you to miss out. Our goal here at Cabot—for the past 50+ years—has always been to help you, and every other American, achieve their financial dreams and live richer than they ever imagined—at a price all can afford. That is the reason we’re making you this offer right now, so you can benefit from this advice and make big profits in this sector. Which is why we charge only $697 for a one-year subscription. That’s quite a bargain, considering all the money waiting to be made. Even better: you get a full 30-day Money-Back Guarantee to see if Michael’s cannabis research is right for you. If not, just let us know and we’ll cancel your subscription and return 100% of your money. You still get to keep your free copy of 3 American Cannabis Companies to Own BEFORE Legalization. Naturally, I couldn’t offer you such a strong guarantee if I didn’t believe that Cabot Cannabis Investor will deliver as promised. I know you won’t be disappointed. All for less than the cost of a daily cup of coffee, you get: - A FREE copy of 3 American Cannabis Companies to Own BEFORE Legalization - The next issue of Cabot Cannabis Investor - Every trade alert—telling you exactly what to buy AND sell - Direct access to Michael Brush to answer your cannabis investing questions So... what are you waiting for? We know Congress is likely to decriminalize … We know these American companies are just waiting for that day to come so they can uplist … We know the U.N. could revisit their 1961 charter at any moment … And then we’ll see an American cannabis boom that everyone will pile into. Cabot Cannabis Investor will show you how you can get in front of the tidal wave of investment. Just click the button below to get started! [Subscribe Now](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fql5nXHsW50kH_H6lZ3mvW37TGwn2BP9FqW8h3Zzq69VHC0W2w4Q5n6MRrtTVRV0SC79nmKzVjtlks1RV6MPW6S3vDr4cWtj1W389xNP5cRS8DW64GFGq5lvNrFW4GvzwF6J0c1JW3pk97L3b-qc7W196nGB3L4KdSN1HfK_ffC0cMW1_Cj-N4Z71mhN2b1RYz7Vqm_V1rkpB1tnqWXW6r96gR5FlfTXW934m2C6212jCW6zSV9w6dpgy4W6vLsWy77k8VFW7vFsGP8lz7mpW7JtkgN6Cf0trVDs6hb7Kzy38W8FDrBd1CSQDxW24qDFc27qjcXW53b2ng3NFDL5N2-tFxbX1kSmVpFw7c5hpgQsVClps66wGzxKW5Vw4rR6vprMZVFD0mp3jh__LN5lqVPMvPWxvN3R0yp5r_Q1df4sq_sR04) Welcome aboard, [NewEdCoburnSignature] Ed Coburn Publisher & President Cabot Wealth Network P.S. “The early bird catches the worm,” it’s been said. And in this case, getting in on the ground level with cannabis investing will position you to reap handsome profits later. [Don’t wait, and act now to get your subscription to Cabot Cannabis Investor.](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fql5nXHsW50kH_H6lZ3q1W8sqLsz8hvpPtV9SgnT206b8zW3zJ-0k3tKzBzW4310JH8265jmW4jcWqS6YS6mgW3SQhqf8lHZFcW3634YK73TGXKW1-Bq_L2LdvNKW84VRNJ2PDrXhW2v8PMl3ZXsJhW5tTKgQ2P7q67W2TwdbQ57f-XJW1nzMGd4_qMZpW8LqCkh3J1Tz0W5n4l2D6D9F58N6Nj_pR2y6_WW7sFBfG29w3JsW2rNKNb2VBQP5W2M5yfc7F7WWJW3DZ1Mg5rjtk-N4d68WP-Cn3GW477Gvp88WmkLW47LXxH97s7CBW5WFcVG6vdl5CW1W9_8z69Qs9dW70c36017MG2LW49h3Hm4WMgVqW52YY7X2cYGWvW8xm3Yj54jh49W2nVzR343rpJtW2HJrCk86HbPKW2ScRDj7rnbkSdRr7LF04) [Facebook](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Frx3qn9gW7lCdLW6lZ3m9W5n0YGY1pCGkBW5054yQ1hld3DW6_-9Mc2dJkNSW4JVDh_1Q6jDPW6YsNFL207-2pN6sXH5lky8FjW70Tgqh8QK50xW88ymXD2gyJs8W2X6B2k1J_y-RW259W595X9V79W6N3RzL92xHDnW4bpNtL950jMYW7rLpVv57wdnMW6bnxS47FBnydN17qwGQN07CYW4VmYRX28M7zTW5bnC1W23-YQvW8V8-DJ3b5VhhW6lLGds72nZ3mW8nyT3V5PXBz0N5NqZjgyhbTTVXd5YG4CyGjzW2NTcgz6QXH6jVlN7nz8djgW8f27hz8004) [LinkedIn](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fs63qn9gW8wLKSR6lZ3mCW6lWGRH3zbsHQVRRfHl18Fj-FW9bc2MV37jbVZM-JV-y-lxNMW2CRmhl70jTN-W90tjjT676fvCN1Xx-95WV-kZW7Jn2wd7Y8tWwW7hmQpq8tJMXZVRSwWr1648YZW1NgM8f1vd2KdW4MRgxY2Xc40YW6SpWwN4grSLGW3PGCrl6j3B1sW67FGps47ZNQ_W62_s6N7_V6mYW59fNs353Lc2nW4vXq3c8Sqpf5W5LyhHC8gk20vW4H0M2P2mdZ04W18qqzh1ljSNmW5vFSdN8LDd5pW4qYZpc8f9zsTV1cC1K5q9096W6fdGW66dl7wCN2R_LV7BvwN0W37-jwJ1mzvHxN8Tphyfgy7kjf95Y1Fj04) [Twitter](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Frx3qn9gW7lCdLW6lZ3nHW680-gW85DKLjW8_2CXq5KMGsjW34hcxC21hMvtW2sX0WC5G540WW8vcCRC7j0xpbW75YR6174bdDvW26rLXS583zSmW38c7hh9fXHvDW7mZGlc9hCsv9W9cQfbg4SJBwTW12876f5SMJVkN7-1MQ9CNKdmW7VrsM-4TCcWXW6sM6832c7gHQW1w_Cqg5l9RsMW7_y1KS35YWMVW2g1yNv4d--6MW70nXkp27bgF3N2WxP9q8Gm0JW8Q6q_S33dmzMW3ZWFlW7pQcyVW6r986_2prv3mW2lXL-f8Q9-twMnfXVXHydhkf2s5clW04) [YouTube](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0FrR3qn9gW7Y8-PT6lZ3msW7vx5z81HZp0mW2xwT_q8qR0VwW1xkZRl7mxMghW66xV6T1pbQQ4W2X_NkW78Bn84N139SjZq7wgTN97XX_kcVq-HW7FbXSm8N0KG-W4kKtpP1H9HzRW6PlvhK8rHh1wW6SVrxs52dshrW2rmzLy4_dNTVW64YDHK1Mx6m-W6mZjrx3l1gbNW4YKq2b7c25ZhW77myrV1jhsn5W5GSh8g98ZGWxV6h0254MstxsVl-dz05k9kYqW1RyjFj4T9b62W3MS-qH7YKFTdV98vbG5Pj-tlN6hVcPstfWT7W6pZC6C90B783N74lF6HTD9YqW80WVJL2tfHQ4f1w-89b04) [Podcast Logo](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0Fs63qn9gW8wLKSR6lZ3pCVxfq-G8z7X1DW8lJv4w8gwq7KW3syQmt3x6QynVfF70c88yjt5W5JysFt5_Jx7HW5RFgPY2WTDDHW88yFlj83hB1mW4bh3Hd4YYTgMW8zcngm95BY2cW82xZnw3ScslwW2GgPT42qzYByW3DLhmH6hBN7MN8rQ8fvy_zd8W4DbfzL8w6RpXVtBQ3g7q1_JLW1TRSNM1Z1fRsW8KF6pr8tcRGyW3SQ9tB9m1-q6W6GpYp325PpJgW3lxwB58q1M9dN6rps9C4-nxLW7jMm_J1KpjSrW96F8CW3MjQl7W1vz7vD5pMjWbW1KdF-K1cSf0jW7R6tbr6_q8Q6W2tqWHV5k7wmzW7YzrP31m4w1tf38jxCW04) Neither Cabot Wealth Network nor our employees are compensated by the companies we recommend. Sources of information are believed to be reliable, but are in no way guaranteed to be complete or without error. Recommendations, opinions or suggestions are given with the understanding that subscribers acting on the information assume all risks. We value your privacy and will not sell or rent your email address to anyone. [View our privacy policy](113/d2zn7704/MXdczl91jckW8MGTC29ddGV9VyCbyQ53g8c6N1m0FrR3qn9gW7Y8-PT6lZ3lXW5GMKH58_6DZSW52B1l21B6QTcW10Zj_Z6WXQWSW7H3f7n8zF5SmW8qQmJG7Pkm-WW4KB_dY7m2tFxW2M9XmH6cJpL8W2_h3w06_ynDQW7K3w7Y4gK9dbW32c22F8Vw8VGW9lc9QH7G3tgPW2vSyhq6ZPNG8W5bt1015w9hXhW1VqD7C58r027W6Mw9sy7LPDHYW7jJWCC4D_jLFN96mhhhCM5gMW33R8XZ5xNVdqW2S-yHh3nqWjmW36Scxk23xVSYW7Bdvl81qQkkDW8HxTtw6cV05lW7n0vLv72djGMW96XM657Jqhp3W2sBqpM94zJ7hW1zF79B2bP5kTf6Kdwkz04) Copyright © 2023 Cabot Wealth Network Cabot Wealth Network, 201 Washington St. Ste 215, Salem, MA 01970, United States, (978) 745-5532 [Unsubscribe]( [Manage preferences](